JANKŮ, Petr, Marian KACEROVSKY, Barbora ZEDNIKOVA, Ctirad ANDRYS, Martina KOLACKOVA, Marcela DRAHOSOVA, Lenka PLISKOVA, Helena ZEMLICKOVA, Romana GERYCHOVÁ, Ondrej SIMETKA, Petr MATLAK, Bo JACOBSSON and Ivana MUSILOVA. Pentraxin 3 in Noninvasively Obtained Cervical Fluid Samples from Pregnancies Complicated by Preterm Prelabor Rupture of Membranes. Fetal Diagnosis and Therapy. Basel: Karger, 2019, vol. 46, No 6, p. 402-410. ISSN 1015-3837. Available from: https://dx.doi.org/10.1159/000499482.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Pentraxin 3 in Noninvasively Obtained Cervical Fluid Samples from Pregnancies Complicated by Preterm Prelabor Rupture of Membranes
Authors JANKŮ, Petr (203 Czech Republic, belonging to the institution), Marian KACEROVSKY (203 Czech Republic, guarantor), Barbora ZEDNIKOVA (203 Czech Republic), Ctirad ANDRYS (203 Czech Republic), Martina KOLACKOVA (203 Czech Republic), Marcela DRAHOSOVA (203 Czech Republic), Lenka PLISKOVA (203 Czech Republic), Helena ZEMLICKOVA (203 Czech Republic), Romana GERYCHOVÁ (203 Czech Republic, belonging to the institution), Ondrej SIMETKA (203 Czech Republic), Petr MATLAK (203 Czech Republic), Bo JACOBSSON (752 Sweden) and Ivana MUSILOVA (203 Czech Republic).
Edition Fetal Diagnosis and Therapy, Basel, Karger, 2019, 1015-3837.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30214 Obstetrics and gynaecology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.095
RIV identification code RIV/00216224:14110/19:00112965
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1159/000499482
UT WoS 000507387300007
Keywords in English Inflammation; Microorganism; Pattern recognition receptor; Preterm birth
Tags 14110411, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 11/5/2020 13:30.
Abstract
Problem: To determine the changes of pentraxin 3 (PTX3) level in noninvasively obtained cervical fluid samples from women with preterm prelabor rupture of membranes (PPROM) based on the presence of microbial invasion of the amniotic cavity (MIAC) and/or intra-amniotic inflammation (IAI), and intra-amniotic infection (the presence of both MIAC and IAI). Methods of Study: A total of 160 women with PPROM were included. Cervical fluid samples were obtained using a Dacron polyester swab and amniotic fluid samples were obtained by transabdominal amniocentesis. Cervical fluid PTX3 levels were assessed using enzyme-linked immunosorbent assay. Results: PTX3 was found in all the cervical fluid samples and its levels were higher in women with MIAC, IAI, and intra-amniotic infection than in women without these conditions. When the women were categorized into four subgroups based on the presence of MIAC and/or IAI, women with intra-amniotic infection had higher cervical fluid PTX3 levels than those with sterile IAI (IAI alone), colonization (MIAC alone), or no MIAC or IAI. A cervical fluid PTX3 level of 11 ng/mL was the best value for identifying the presence of intra-amniotic infection in women with PPROM. Conclusions: PTX3 is a constituent of cervical fluid of women with PPROM. Cervical fluid PTX3 level reflects the situation in the intra-amniotic compartments of women with PPROM. Cervical fluid PTX3 is a potential marker for the noninvasive identification of intra-amniotic infection in PPROM.
PrintDisplayed: 14/7/2024 21:15